Pair Name | Biochanin A, Fluorouracil | ||
Phytochemical Name | Biochanin A (PubChem CID: 5280373 ) | ||
Anticancer drug Name | Fluorouracil (PubChem CID: 3385 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Biochanin A, Fluorouracil | |||
Disease Info | [ICD-11: 2C60] | Breast cancer | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Down-regulation | Expression | AKT1 | hsa207 |
Down-regulation | Expression | BIRC5 | hsa332 | |
Down-regulation | Expression | CCND1 | hsa595 | |
Down-regulation | Expression | ESR1 | hsa2099 | |
Down-regulation | Expression | MMP2 | hsa4313 | |
Down-regulation | Expression | VEGFA | hsa7422 | |
In Vitro Model | MCF-7 | Invasive breast carcinoma of no special type | Homo sapiens (Human) | CVCL_0031 |
MDA-MB-231 | Breast adenocarcinoma | Homo sapiens (Human) | CVCL_0062 | |
In Vivo Model | Ehrlich solid-phase carcinoma was inducedviathe subcutane-ous inoculation of 0.2 ml of ascetic fluid, containing 2.5×10⁶ EACcells, into the right thigh of the hind limb of each mouse. | |||
Result | The synergistic antitumor effect of Bio-A/ 5-FU combination can be, at least partly, attributed to Bio-A-mediated suppression of ER-α/Akt axis and the augmentation of 5-FU-mediated proapoptotic effects. |
No. | Title | Href |
---|---|---|
1 | The natural isoflavone Biochanin-A synergizes 5-fluorouracil anticancer activity in vitro and in vivo in Ehrlich solid-phase carcinoma model. Phytother Res. 2022 Mar;36(3):1310-1325. doi: 10.1002/ptr.7388. | Click |